Skip to main content
LMRI
NASDAQ Industrial Applications And Services

Lumexa Imaging Reports Q1 Profit, Strong EPS Growth, and Strategic Expansion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$10.5
Mkt Cap
$1.009B
52W Low
$7.23
52W High
$19.45
52W Position info
45% above low
Off High info
46% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

LMRI sits 45% above its 52-week low of $7.23.

Summary

Lumexa Imaging reported a swing to profitability in Q1 2026 with strong adjusted EPS growth and announced new center expansions, while reiterating its full-year guidance.


Key Events · Earnings and Guidance · LMRI

  • Q1 Net Income Achieved

    The company reported a net income of $1.7 million for Q1 2026, a significant improvement from a net loss of $7.7 million in the prior year period.

  • Strong Adjusted EPS Growth

    Adjusted EPS increased to $0.18 per share in Q1 2026, up from $0.04 per share in Q1 2025.

  • Strategic Expansion with New Centers

    Lumexa Imaging announced the addition of four new centers, comprising two strategic tuck-in acquisitions and two de novo centers, advancing its growth strategy.

  • Full-Year Guidance Reiterated

    The company reiterated its full-year 2026 outlook for consolidated revenues, Adjusted EBITDA, and Adjusted EPS, indicating confidence in its financial targets.


Analysis · LMRI · Industrial Applications And Services

Lumexa Imaging Holdings, Inc. reported a significant turnaround in its first quarter 2026 financial results, moving from a net loss to a net income of $1.7 million. The company also achieved strong adjusted EPS growth and announced the addition of four new imaging centers, including two strategic acquisitions, demonstrating continued operational expansion. Full-year guidance was reiterated, signaling management's confidence in sustained performance.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LMRI was trading at $10.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $7.23 to $19.45. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMRI - Latest Insights

LMRI
Aug 13, 2026, 2:54 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $13.77 info
Change: +$1.47 (+12%) info
Market Cap: $1.322B info
LMRI
Aug 12, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $13.77 info
Change: +$1.77 (+15%) info
Market Cap: $1.322B info
LMRI
Aug 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.06
Real-time Price: $13.77 info
Change: +$1.71 (+14%) info
Market Cap: $1.322B info
LMRI
Jun 30, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.28
Real-time Price: $13.77 info
Change: +$2.49 (+22%) info
Market Cap: $1.322B info
LMRI
Jun 30, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.28
Real-time Price: $13.77 info
Change: +$2.49 (+22%) info
Market Cap: $1.322B info